GGrantIndex
← Leaderboards

Jacqueline Michele Achkar

Albert Einstein College Of Medicine

$9,972,918
Attributed
$9,972,918
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.5M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,972,918 · 8

By mechanism

R01$8,376,092 · 3
R21$917,567 · 2
K23$665,550 · 1
M01$13,709 · 2

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Tuberculosis

Research focus

TuberculosisAntibodiesProteinsMycobacterium TuberculosisBaseSamplingCause Of DeathResponseImmunoglobulin GSpecificityDetectionDiagnosisImmune ResponseAntigensInfectionPublishingSouth AfricanSerumMonoclonal AntibodiesMycobacterialLung DiseasesNucleic AcidsImmuneImmunoassay

Grant awards (27)

Non-sputum-based biomarkers for the detection of tuberculosis$850,711
R01 · FY2025 · AI · contact PI
Characteristics and protective efficacy of human antibodies against M. tuberculosis$716,093
R01 · FY2023 · AI · contact PI
Characteristics and protective efficacy of human antibodies against M. tuberculosis$44,856
R01 · FY2023 · AI · contact PI
Characteristics and protective efficacy of human antibodies against M. tuberculosis$716,093
R01 · FY2022 · AI · contact PI
Characteristics and protective efficacy of human antibodies against M. tuberculosis$88,032
R01 · FY2022 · AI · contact PI
Characteristics and protective efficacy of human antibodies against M. tuberculosis$773,048
R01 · FY2021 · AI · contact PI
Characteristics and protective efficacy of human antibodies against M. tuberculosis$768,623
R01 · FY2020 · AI · contact PI
Host biomarkers for M. tuberculosis infection activity in HIV-infected persons$621,194
R01 · FY2020 · AI · contact PI
Characteristics and protective efficacy of human antibodies against M. tuberculosis$788,818
R01 · FY2019 · AI · contact PI
Host biomarkers for M. tuberculosis infection activity in HIV-infected persons$667,954
R01 · FY2019 · AI · contact PI
Host biomarkers for M. tuberculosis infection activity in HIV-infected persons$399,489
R01 · FY2018 · AI · contact PI
Host biomarkers for M. tuberculosis infection activity in HIV-infected persons$286,465
R01 · FY2018 · AI · contact PI
Antibodies associated with protection against tuberculosis in nonhuman primates$105,153
R21 · FY2018 · AI · contact PI
Antibodies associated with protection against tuberculosis in nonhuman primates$103,387
R21 · FY2018 · AI · contact PI
Host biomarkers for M. tuberculosis infection activity in HIV-infected persons$817,851
R01 · FY2017 · AI · contact PI
Antibodies associated with protection against tuberculosis in nonhuman primates$264,807
R21 · FY2017 · AI · contact PI
Host biomarkers for M. tuberculosis infection activity in HIV-infected persons$836,865
R01 · FY2016 · AI · contact PI
Novel serological biomarker for rapid tuberculosis diagnosis$178,580
R21 · FY2014 · AI · contact PI
Novel serological biomarker for rapid tuberculosis diagnosis$30,170
R21 · FY2014 · AI · contact PI
Novel serological biomarker for rapid tuberculosis diagnosis$235,470
R21 · FY2013 · AI · contact PI
Immunodiagnostic Tests for the Rapid Diagnosis of Tb$133,110
K23 · FY2011 · AI · contact PI
Immunodiagnostic Tests for the Rapid Diagnosis of Tb$133,110
K23 · FY2010 · AI · contact PI
Immunodiagnostic Tests for the Rapid Diagnosis of Tb$133,110
K23 · FY2009 · AI · contact PI
Immunodiagnostic Tests for the Rapid Diagnosis of Tb$133,110
K23 · FY2008 · AI · contact PI
IMMUNODIAGNOSTIC TESTS FOR THE RAPID DIAGNOSIS OF TB$10,987
M01 · FY2008 · RR · contact PI
Immunodiagnostic Tests for the Rapid Diagnosis of Tb$133,110
K23 · FY2007 · AI · contact PI
IMMUNODIAGNOSTIC TESTS FOR THE RAPID DIAGNOSIS OF TB$2,722
M01 · FY2007 · RR · contact PI